Wells Fargo & Company Pacific Biosciences Of California, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 129,221 shares of PACB stock, worth $228,721. This represents 0.0% of its overall portfolio holdings.

Number of Shares

129,221

Previous 148,637 13.06%

Holding current value

$228,721

Previous $203,000 7.88%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$1.2 - $2.17 $23,299 - $42,132	-19,416 Reduced 13.06%	129,221 $219,000
Q2 2024 Aug 13, 2024	BUY	$1.36 - $3.65 $9,082 - $24,374	6,678 Added 4.7%	148,637 $203,000
Q1 2024 May 10, 2024	BUY	$3.52 - $9.59 $145,801 - $397,227	41,421 Added 41.2%	141,959 $532,000
Q4 2023 Feb 09, 2024	BUY	$5.97 - $10.36 $133,560 - $231,773	22,372 Added 28.62%	100,538 $986,000
Q3 2023 Nov 13, 2023	SELL	$8.23 - $13.93 $397,780 - $673,278	-48,333 Reduced 38.21%	78,166 $652,000
Q2 2023 Aug 15, 2023	BUY	$9.97 - $14.05 $544,571 - $767,425	54,621 Added 75.99%	126,499 $1.68 Million
Q1 2023 May 12, 2023	BUY	$7.94 - $12.02 $279,583 - $423,248	35,212 Added 96.03%	71,878 $832,000
Q4 2022 Feb 13, 2023	BUY	$5.67 - $11.2 $25,821 - $51,004	4,554 Added 14.18%	36,666 $299,000
Q3 2022 Nov 14, 2022	BUY	$3.93 - $8.57 $16,855 - $36,756	4,289 Added 15.42%	32,112 $187,000
Q2 2022 Aug 12, 2022	SELL	$4.02 - $10.43 $360,453 - $935,205	-89,665 Reduced 76.32%	27,823 $123,000
Q1 2022 May 16, 2022	SELL	$8.43 - $20.9 $829,941 - $2.06 Million	-98,451 Reduced 45.59%	117,488 $1.07 Million
Q4 2021 Feb 14, 2022	BUY	$19.26 - $30.08 $342,153 - $534,371	17,765 Added 8.96%	215,939 $4.42 Million
Q3 2021 Nov 15, 2021	SELL	$24.86 - $35.02 $979,210 - $1.38 Million	-39,389 Reduced 16.58%	198,174 $5.06 Million
Q2 2021 Aug 16, 2021	BUY	$22.3 - $36.02 $1.07 Million - $1.72 Million	47,789 Added 25.18%	237,563 $8.31 Million
Q1 2021 May 13, 2021	SELL	$26.38 - $51.15 $3.67 Million - $7.12 Million	-139,252 Reduced 42.32%	189,774 $6.32 Million
Q4 2020 Feb 09, 2021	BUY	$10.5 - $28.5 $2 Million - $5.43 Million	190,651 Added 137.78%	329,026 $8.54 Million
Q3 2020 Nov 05, 2020	BUY	$3.61 - $9.87 $55,283 - $151,149	15,314 Added 12.44%	138,375 $1.37 Million
Q2 2020 Aug 13, 2020	BUY	$2.65 - $4.03 $76,773 - $116,753	28,971 Added 30.79%	123,061 $423,000
Q1 2020 May 14, 2020	BUY	$2.36 - $5.26 $222,052 - $494,913	94,090 New	94,090 $288,000

Others Institutions Holding PACB

# of Institutions

255

Shares Held

228M

Call Options Held

745K

Put Options Held

1.23M

View Full List

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $398M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

More about PACB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Pacific Biosciences Of California, Inc. Transaction History